Malignant Brain Neoplasm — Trials

Malignant Brain Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

636 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 192
Recruiting: 110
Ph III recruiting: 4
Growth YoY: +6.3%
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (99)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04051047	Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma	withdrawn	Early Phase 1	0	University of Michigan Rogel Cancer CenterOTHER	1	Nov 27, 2019	clinicaltrials

Data updated 23 days agoSource updated Nov 27, 2019source: clinicaltrials